REFERENCES
- Young G, Manco-Johnson M, Gill J C, et al. Clinical manifestations of the prothrombin G20210A mutation in children: a pediatric coagulation consortium study. J Thromb Haemost. 2003; 1: 1–5, [CROSSREF]
- Junker R, Koch H G, Auberger K, Münchow N, Ehrenforth S, Nowak-Göttl U. Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia. Arterioscler Thromb Vasc Biol. 1999; 19: 2568–2572, [PUBMED], [INFOTRIEVE], [CSA]
- Franco R F, Trip M D, Ten Cate H, et al. The 20210 G-A mutation in the 3′-untranslated region of the prothrombin gene and the risk for arterial thrombotic disease. Br J Haematol 1999; 104: 50–54, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Akar N, Akar E, Deda G, Sipahi T, Orsal A. Factor V 1691 G-A, prothrombin 20210 G-A, and methylenetetrahydrofolate reductase 677 C-T variants in Turkish children with cerebral infarct. J Child Neurol. 1999; 14: 749–751, [PUBMED], [INFOTRIEVE], [CSA]
- Rosendaal F R, Doggen C JM, Zivelin A, et al. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 1998; 79: 706–708, [PUBMED], [INFOTRIEVE], [CSA]
- De Stefano V, Chiusolo P, Paciaroni K, et al. Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischaemic disease in young patients. Blood 1998; 91: 3562–3562, [PUBMED], [INFOTRIEVE], [CSA]
- Nowak-Gottl U, Strater R, Heinecke A, et al. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors for spontaneous ischemic stroke in childhood. Blood 1999; 94: 3678–3682, [PUBMED], [INFOTRIEVE], [CSA]